Anti-Cancer Activities of Cu(?) Ion Solution in Progression and Development against Cancer and Tumor Cells

Authors

  • D. Sc Tsuneo Ishida

Keywords:

copper(?) and copper(?) ions, cancer and tumor cells, angiogenesis, reactive oxygen species (ROS), DNA base-pairs

Abstract

Copper plays important role of cancer cell progression and development, malignant cell growth, and angiogenesis in invasive and metastatic growths. Specially, angiogenesis and autophagy have been worthy of new blood vessel formations and fusion proteins respectively for malignant and tumor cell growths. Schiff base copper(Ⅱ) complexes have anti-proliferative activity against cancer cells. Cu 2+ ions play an important role as pro-cancer factor in tumor tissues especially in tumor angiogenesis, invasion, and metastasis.Specially, Cu 2+ ions as Cu-chelating complex can inhibit formation of new blood vessel of tumor cell against angiogenesis in cancer.Promotion and development of cancer tissues have been proceeding with homeostatic imbalances of copper, in which can be caused by the uptake of excessive amounts of copper and some genetic defects.Cancer cell killing via ROS that superoxide anion O 2 -, hydroxyl radical ・OH, hydrogen peroxide H 2 O 2 mainly may be performed under cellular Cu 2+ ions induced ROS generations in tumor cells. Finally, Cu 2+ -H 2 O 2 induced DNA base-pairs inhibition can be regarded as being undergone to DNA damages due to Cu 2+ -complex formations within DNA base-pairs G≡C, A=T by Cu 2+ substitutions in hydrogen bonds of DNA base-pairs.

How to Cite

Anti-Cancer Activities of Cu(?) Ion Solution in Progression and Development against Cancer and Tumor Cells. (2017). Global Journal of Medical Research, 17(22), 7-16. https://medicalresearchjournal.org/index.php/GJMR/article/view/

References

V. Karrera, Djoko (2015) Copper and zinc toxicity and its role in innate immune defense against bacterial pathogens. 8, 1-13.

K. Raju, G. Alessandri, M. Ziche, P. Gullino (1982) Ceruloplasmin, copper ions, and angiogenesis. 69, 1183-1188.

Pena MMO, Lee J, Thiele DJ (1999) A Delicate Balance: Homeostatic Control of Copper Uptake and DistributionⅠ J.Nutr. 129(7), 1251-1260. https://doi.org/10.1093/jn/129.7.1251

Lydia Finney, Stefan Vogt, Tohru Fukai, David Glesne (2009) Copper and angiogenesis:Unravelling a relationship key to cancer progression. 36(1), 88-94.

F. Wang, P. Jiao, M. Qi, M. Frezza, B. Yan (2010) Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry. 17(25), 2685-2698. https://doi.org/10.2174/092986710791859315

Yan Xiao Molecular study on copper-mediated tumor proteasome inhibition and cell death. 37(1), 81-87.

Ying-Ying Li (2017) Autophagic mechanism in anticancer immunity: its pros and cons for cancer therapy. 18(6), 1297. https://doi.org/10.3390/ijms18061297

T. Theophanides, J. Anastassopoulou (2002) Copper and carcinogenesis. 42, 57-64.

Haseeb Zubair (2016) Mobilization of intracellular copper by gossypol and apogossypolone leads to reactive oxygen species-mediated cell death: putative anticancer mechanism, Int J. 17, 973-985.

trientine, suppresses tumor development (2001) The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. 94, 768-773.

Zhi-Min Hong-Yan Xie (2017) Tumor microenvironment: driving forces and potential therapeutic target for breast cancer metastasis. 36, 36-46.

N. Margetis (2017) K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas. 31, 527-542.

(2010) Haplo-insufficiency: a driving force in cancer. 223, 137-146.

Maamoun Fatfat (2012) Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. 14(1), 527-539. https://doi.org/10.1186/1471-2407-14-527

Huacheng He (2016) Cancer cell selective-killing polymer/copper combination. 4(1), 115-120.

Stephanie Blockhuys, Pernilla Stafshede (2017) Roles of copper-binding proteins in breast cancer. 18, 871-881.

G. V L Goodman, S. Brewer, Merajver (2004) V L Goodman, G J Brewer, and S D Merajver, Copper deficiency as an anti-cancer strategy, Endocrine-Related Cancer, 2004. 11, 255-263.

Arch mechanisms (2014) Copper: toxicological relevance and mechanisms. 88(11). https://doi.org/10.1007/s00204-014-1355-y

Tsuneo Ishida (2016) The consideration of biocidal activities of Cu2+ solutions in Gram-positive and Gram-negative bacteria cell walls on the results of the susceptibility tests. 55, 1-18.

Tsuneo Ishida (2016) Bacteriolyses of Cu2+ solution on bacterial cell walls/cell membrane and DNA basepairing damages. 27(4), 151-161.

Vasanthi Ramachandran, B. Chandrakala, Vidya Kumar, Veeraraghavan Usha, Suresh Solapure, Sunita de Sousa (2006) Screen for Inhibitors of the Coupled Transglycosylase-Transpeptidase of Peptidoglycan Biosynthesis in Escherichia coli. 50(4), 1425-1432. https://doi.org/10.1128/aac.50.4.1425-1432.2006

Jessica Humann, Laurel Lenz (2009) Bacterial Peptidoglycan-Degrading Enzymes and Their Impact on Host Muropeptide Detection. 1(2), 88-97. https://doi.org/10.1159/000181181

Kenyon G.Daniel (2005) Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. 7(6), R897-R908. https://doi.org/10.1186/bcr1322

Zhen Zhang (2012) 1,10-phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome. 17(8), 1257-1267.

Mohd Farhan (2016) Cancer therapy by catechins involves redox cycling of copper ions and generation of reactive oxygen species. 8(2), 37-53. https://doi.org/10.3390/toxins8020037

(2013) Cancer Development, Progression, and Therapy: An Epigenetic Overview. 14(10), 1087-2111. https://doi.org/10.3390/ijms141021087

Roberta Peruzzo, Lucia Biasutto, Ildikò Szabò, Luigi Leanza (2016) L.Leanza: Impact of intracellular ion channels on cancer development and progression. 45(7), 685-707. https://doi.org/10.1007/s00249-016-1143-0

Jie Wang, Jing Yi (2008) Jie Wang and Jing Yi: Cancer cell killing via ROS,Cancer Biology & Therapy, 2008;7:. 7, 1875-1884.

breast progression, cancer cells (2011) Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. 80, 347-368.

P. Lames, Kehrer (2000) The Haber-Weiss reaction and mechanisms of toxicity. 149, 43-50.

ENGINEERINGS (2009) Fenton reactioncontroversy concerning the chemistry. 16(3), 347-358.

YoungsikSeo, Young-Sik Cho, Young-Duk Huh, Haonyyong Park (2016) Copper ion from Cu2O crystal induces AMPK-mediated autography via superoxide in endothelial cells. 39(3), 195-203.

Georg Franziska van Zijl, Wolfgang Krupitza, Mikulits (2011) Franziska van Zijl, Georg Krupitza, Wolfgang Mikulits: Initial steps of metastasis : Cell invasion and endothelial transmigration, Mutation Research, 2011. 728, 23-34.

Andrew G (2015) Clark and D.Matic Vignjevic: Modes of cancer cell invasion and the role of the microenvironment, Current Opinion in Cell Biology, 2015. 36, 13-22.

Joan Massagué, Anna Obenauf (2016) Obenauf: Metastatic Colonization, Nature 2016 Jan 21. 529(7586), 298-306.

Y. Wang (2013) Cuprous oxide nanoparticle inhibit the growth and metastasis of melanoma by targeting mitochondria. 4(8), e783-e783. https://doi.org/10.1038/cddis.2013.314

Konarikova K (2016) Autophagy in MCF-7 cancer cells induced by Cu(Ⅱ) complexes. 8(16), 1221-1224.

Xue Yang (2015) The role of autophagy induced by tumor microenvironment in different cells and stages of cancer. 5(1), 14-25. https://doi.org/10.1186/s13578-015-0005-2

Edward Harris (2004) Edward D.Harris: A requirement for copper in angiogenesis, Nutrition Reviews, 2004. 62(2), 60-64.

Natalia Mroczek-Sosnowska, Int molecular level (2015) Nanoparticles of copper stimulate angiogenesis at systemic and molecular level. 16, 4838-4849.

George J.Brewer, SolfiaD.Merajver (2002) Cancer therapy with tetrathiomolybdate: Antiangiogenesis by lowering body copper. 1(4), 327-337.

Quintin Pan (2002) Quintin Pan, et al :Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis, Cancer Research 2002. 62, 4854-4859. https://doi.org/10.61918/rgaa1950

Steven Brem (1990) Steven S.Brem et al: Inhibition of angiogenesis and tumor growth in the brain, American J. 137(5), 1121. https://doi.org/10.61918/rgaa1950

diseases fibrosis, J. inflammation (2003) Copper-lowering therapy with tetrathiomolybdate for cancer and diseases of fibrosis and inflammation. 16, 191-199.

K. Maskos The interaction of metal ions with nucleic acids. NMR study of the copper(Ⅱ) interaction with inosine derivatives. 28, 317-335.

Patricia Erebi Tawari (2015) The cytotoxic mechanisms of disulfiram and copper(Ⅱ) in cancer cells. 4, 1439-1441.

Udeme, S. Minakiri (2014) Minakiri: Disulfiram and copper gluconate in cancer chemotherapy; a review of the literature, Cancer Research J. 2(5), 88-92.

M. Baile (2015) Baile M.B. et al: ANTICANCER COPPER COMPLEX. 4(8), 58-66.

D. Montagner (2015) et al : DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclearbis (triazacyclonane) copper complex. 145, 101-107. https://doi.org/10.1016/j.jinorgbio.2015.01.013

Cristina Trejo-Solis (2012) Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation. 12, 156.

A. Singh (2011) et al: Synthesis, structure and anticancer activities of copper(Ⅱ) complexes, Indian J. 474-483.

Maryam Hajrezaie (2014) A Schiff base-derived copper(Ⅱ) complex is a potent inducer of apoptosis in colon cancer cells by activating the intrinsic pathway. 2014, 12 pages. https://doi.org/10.1155/2014/540463

Di Chen, Q. Dou (2008) New uses for copperbinding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer. 12(6), 739-748. https://doi.org/10.1517/14728222.12.6.739

Maamoun Fatfat (2014) Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. 14(1), 527-539. https://doi.org/10.1186/1471-2407-14-527

Anti-Cancer Activities of Cu(?) Ion Solution in Progression  and Development against Cancer and Tumor Cells

Published

2017-10-02

How to Cite

Anti-Cancer Activities of Cu(?) Ion Solution in Progression and Development against Cancer and Tumor Cells. (2017). Global Journal of Medical Research, 17(22), 7-16. https://medicalresearchjournal.org/index.php/GJMR/article/view/